News

Deal Announcements

CeraPedics Nets Series B Venture Capital Financing

Wednesday, April 8, 2009 5:49:00 AM PDT | VentureDeal Staff
Westminster, Colorado  --  Medical device company CeraPedics has secured $15 million in its second round of institutional venture capital funding.

CeraPedics is developing orthopedic bone substitute products that utilize its proprietary small peptide called P-15.

NGN Capital was the lead investor in the round, which also included OrbiMed. The company said that the financing would be used to increase its investment in sales and marketing as well as fund ongoing FDA clinical trials. For some of its technologies under development.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1